178 related articles for article (PubMed ID: 20803552)
1. Modulation of GEF-H1 induced signaling by heparanase in brain metastatic melanoma cells.
Ridgway LD; Wetzel MD; Marchetti D
J Cell Biochem; 2010 Dec; 111(5):1299-309. PubMed ID: 20803552
[TBL] [Abstract][Full Text] [Related]
2. Heparanase-induced GEF-H1 signaling regulates the cytoskeletal dynamics of brain metastatic breast cancer cells.
Ridgway LD; Wetzel MD; Ngo JA; Erdreich-Epstein A; Marchetti D
Mol Cancer Res; 2012 Jun; 10(6):689-702. PubMed ID: 22513363
[TBL] [Abstract][Full Text] [Related]
3. Heparanase Modulates Shh and Wnt3a Signaling in Human Medulloblastoma Cells.
Ridgway LD; Wetzel MD; Marchetti D
Exp Ther Med; 2011 Mar; 2(2):229-238. PubMed ID: 21442027
[TBL] [Abstract][Full Text] [Related]
4. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling.
Liao YC; Ruan JW; Lua I; Li MH; Chen WL; Wang JR; Kao RH; Chen JH
Oncogene; 2012 Jun; 31(25):3086-97. PubMed ID: 22002306
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; McQuillan DJ; Spohn WC; Carson DD; Nicolson GL
Cancer Res; 1996 Jun; 56(12):2856-63. PubMed ID: 8665526
[TBL] [Abstract][Full Text] [Related]
7. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge.
Nalbant P; Chang YC; Birkenfeld J; Chang ZF; Bokoch GM
Mol Biol Cell; 2009 Sep; 20(18):4070-82. PubMed ID: 19625450
[TBL] [Abstract][Full Text] [Related]
8. Heparanase mechanisms of melanoma metastasis to the brain: Development and use of a brain slice model.
Murry BP; Blust BE; Singh A; Foster TP; Marchetti D
J Cell Biochem; 2006 Feb; 97(2):217-25. PubMed ID: 16288472
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of GEF-H1 promotes colon cancer progression by RhoA signaling.
Cao J; Yang T; Tang D; Zhou F; Qian Y; Zou X
Pathol Res Pract; 2019 May; 215(5):1012-1019. PubMed ID: 30846413
[TBL] [Abstract][Full Text] [Related]
10. The guanine nucleotide exchange factor Tiam1: a Janus-faced molecule in cellular signaling.
Boissier P; Huynh-Do U
Cell Signal; 2014 Mar; 26(3):483-91. PubMed ID: 24308970
[TBL] [Abstract][Full Text] [Related]
11. GEF-H1 couples nocodazole-induced microtubule disassembly to cell contractility via RhoA.
Chang YC; Nalbant P; Birkenfeld J; Chang ZF; Bokoch GM
Mol Biol Cell; 2008 May; 19(5):2147-53. PubMed ID: 18287519
[TBL] [Abstract][Full Text] [Related]
12. Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
Marchetti D; Nicolson GL
J Investig Dermatol Symp Proc; 1997 Aug; 2(1):99-105. PubMed ID: 9487024
[TBL] [Abstract][Full Text] [Related]
13. Neurotrophin stimulation of human melanoma cell invasion: selected enhancement of heparanase activity and heparanase degradation of specific heparan sulfate subpopulations.
Marchetti D; Nicolson GL
Adv Enzyme Regul; 1997; 37():111-34. PubMed ID: 9381967
[TBL] [Abstract][Full Text] [Related]
14. GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling.
Cheng IK; Tsang BC; Lai KP; Ching AK; Chan AW; To KF; Lai PB; Wong N
J Pathol; 2012 Dec; 228(4):575-85. PubMed ID: 22847784
[TBL] [Abstract][Full Text] [Related]
15. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
16. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes contribute to the brain-metastatic specificity of melanoma cells by producing heparanase.
Marchetti D; Li J; Shen R
Cancer Res; 2000 Sep; 60(17):4767-70. PubMed ID: 10987284
[TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases.
Ren Y; Li R; Zheng Y; Busch H
J Biol Chem; 1998 Dec; 273(52):34954-60. PubMed ID: 9857026
[TBL] [Abstract][Full Text] [Related]
19. Latent heparanase facilitates VLA-4-mediated melanoma cell binding and emerges as a relevant target of heparin in the interference with metastatic progression.
Gerber U; Hoß SG; Shteingauz A; Jüngel E; Jakubzig B; Ilan N; Blaheta R; Schlesinger M; Vlodavsky I; Bendas G
Semin Thromb Hemost; 2015 Mar; 41(2):244-54. PubMed ID: 25682080
[TBL] [Abstract][Full Text] [Related]
20. Heparanase facilitates cell adhesion and spreading by clustering of cell surface heparan sulfate proteoglycans.
Levy-Adam F; Feld S; Suss-Toby E; Vlodavsky I; Ilan N
PLoS One; 2008 Jun; 3(6):e2319. PubMed ID: 18545691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
